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MicroscopyCationic antimicrobial peptides (CAMPs) are novel candidates for drug development. Here we describe
design of six short and potent CAMPs (SA-1 to SA-6) based on a minimalist template of 12 residues H+
HHG+HH+HH+NH2 (where H: hydrophobic amino acid and +: charged hydrophilic amino acid). Designed
peptides exhibit good antibacterial activity in micro molar concentration range (1-32 μg/ml) and rapid
clearance of Gram-positive and Gram-negative bacterial strains at concentrations higher than MIC. For
elucidating mode of action of designed peptides various biophysical studies including CD and Trp
ﬂuorescence were performed using model membranes. Further based on activity, selectivity and membrane
bound structure; modes of action of Trp rich peptide SA-3 and template based peptide SA-4 were compared.
Calcein dye leakage and transmission electron microscopic studies with model membranes exhibited
selective membrane active mode of action for peptide SA-3 and SA-4. Extending our work from model
membranes to intact E. coli ATCC 11775 in scanning electron micrographs we could visualize different
patterns of surface perturbation caused by peptide SA-3 and SA-4. Further at low concentration rapid
translocation of FITC-tagged peptide SA-3 into the cytoplasm of E. coli cells without concomitant membrane
perturbation indicates involvement of intracellular targeting mechanism as an alternate mode of action as
was also evidenced in DNA retardation assay. For peptide SA-4 concentration dependent translocation into
the bacterial cytoplasm along with membrane perturbation was observed. Establishment of a non speciﬁc
membrane lytic mode of action of these peptides makes them suitable candidates for drug development.tides; ATCC, American Type
holesterol; DPPC, 1,2-dipalmi-
yl-sn-Glycero-3-phospho-(1'-
nate; Fmoc, Fluorenyl methoxy
um inhibitory concentration;
hospho tungstic acid; RPHPLC,
phy; SEM, Scanning Electron
smission Electron Microscopy
ry, Institute of Genomics and
667471.
asha).
.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Infections caused bymultidrug-resistant Gram-positive and Gram-
negative pathogens such as methicillin-resistant Staphylococcus
aureus (MRSA), vancomycin-resistant Enterrococci (VRE), drug-resis-
tant Pseudomonas aeruginosa and Acenatobacter spp. has become a
serious problem worldwide [1–3]. Although there are some antibac-terial drugs in the market but withdrawal of major drug companies
from the antibacterial drug development market has lead to a lack of
new molecules in the clinics [4,5]. Therefore search for innovative
antibacterial agents with novel mode of action has become inevitable.
Although peptides are high-priced solution as a new class of
antibiotics, their multifaceted roles in innate immunity, LPS neutra-
lisation, wound and burn healing makes them attractive candidates
for drug development [6]. With a non-speciﬁc cell lytic mode of action
and a broad range of activity CAMPs can combat attack of pathogens
including bacteria, fungi, viruses, protozoa and cancerous cells [7]. A
multicellular organism in general attack microbes with multiple
peptides at the same time, and each peptide with a different primary
sequence and secondary structure preference may have a different
mode of action thus it would be difﬁcult for the bacteria to endure or
gain resistance against CAMPs [8]. Therefore potential of CAMPs can
be harnessed by rational designing of short, potent and highly speciﬁc
peptide therapeutics.
CAMPs represent a diverse array of small peptides with length of
12–60 amino acid residues, found in almost all organisms including
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of CAMPs based on secondary structure includes family of amphi-
pathic α-helical peptides like cecropins, β-sheet peptides like
defensins, loop structured peptides like bactenecins and peptides
rich in one particular amino acid like indolicidin [10]. Among the
major modulators that determine antimicrobial activity of a peptide
are net positive charge, length, hydrophobicity and amphipathic
structure [11]. Initial interactions between a peptide and bacterial
membranes are electrostatically driven as bacterial membranes are
composed of negatively charged and zwitterionic phospholipids
therefore positive charge on these peptides helps them to bind to
these membranes [12]. Amphipathicity plays a key role in peptide
lipid interactions as acquisition of a well deﬁned amphipathic
structure in the vicinity of membrane lowers the thermodynamic
cost of peptide partitioning in lipid membranes. This energy lowering
helps in binding and insertion of peptides to bacterial membranes that
lead to bacterial cell death.
For the design of novel, short and potent CAMPs various research
groups have made use of a sequence template approach whereby
based on amphipathicity novel peptides with amino acid residues
occurring most frequently in the sequences of CAMPs were employed
to design cell selective antimicrobial agents [13,14]. The speciﬁc mode
of action of CAMPs has not been deciphered as yet because of the fact
that they do not attack a single target such as a membrane receptor or
an enzyme in bacterial pathogens [15,16]. It has been established that
if not all, most of the CAMPs aremembrane active and need to interact
with the bacterial membrane to perturb the membrane or to target
intracellular components. Among the major hypothesis proposed for
mode of action of membrane permeabilizing peptides a few are (a)
loss of ion concentration gradient across the membrane leading to
leakage of cellular contents (b) intracellular targeting after internal-
ization like DNA and RNA synthesis inhibition, enzyme deactivation
and lipid binding [17] (c) generation of pores that admit water but do
not allow other osmotically active substances to pass, which leads to
swelling of the bacterial cell and ﬁnally rupturing of the cell. A novel
mode of action proposed recently for activity of a group of
conformationally amphipathic molecules includes lipid segregation
caused upon peptide lipid interaction that ends up in membrane
damage of bacteria due to clustering of anionic lipids [18].
In the present study we undertook synthesis of a series of short
cationic peptides based on an amphipathic template of 12 amino acid
residues with different secondary structure preferences in membrane
milieu. Antibacterial activities of the designed peptides against
various Gram-positive and Gram-negative bacterial strains were
tested. Toxicity to hRBC was evaluated as a measure to check
selectivity of designed peptides. Based on the results of antimicrobial
activity, cytotoxicity, CD spectra and Trp ﬂuorescence in our further
studies, we compared mode of action of two of the lead peptides SA-3
and SA-4 by employing biophysical, microscopic, ﬂow cytometric and
DNA gel retardation tools.
In the studies bovine peptide indolicidin (rich in Trp residues) was
included as a standard CAMP because of its comparable length and
well established mode of action.
2. Materials and methods
2.1. Chemicals
Fmoc-Protected amino acids and resins were purchased fromNova
Biochem. Piperidin, N-hydroxybenzotrizole (HOBt), triﬂuoro ethanol
(TFE), triﬂuoro acetic acid (TFA), N-methyl pyrrolidinone (NMP), N,N-
diisopropylcarbodiimide (DIPCDI), dimethyl sulphoxide (DMSO) and
triisopropyl silane (TIS) were purchased from Sigma Chemical Co.
DPPC, DPPG were purchased from Avanti Polar Lipids. Calcein,
propidium iodide, FITC and buffer material were purchased from
Sigma Chemicals Co. All solvents used for the puriﬁcation were HPLCgrade and obtained from Sigma chemical Co. Dimethylformamide
(DMF) and dichloromethane (DCM) were obtained from Merck. DMF
was double distilled prior to use.
2.2. Bacterial strains
Bacterial strains used in this study were as follows, Escherichia coli
(ATCC 11775), P. aeruginosa (ATCC 25668), S. aureus (ATCC 9144),
Bacillus subtilis (ATCC 6633), Acinetobactor spp. (clinical isolate), and
E. coli (clinical isolate). Clinical isolates used in the present study were
collected from hospital patients from All India institute of Medical
Sciences, New Delhi, India. All the strains used in the study were
maintained and tested on Mueller-Hinton broth and agar (Himedia).
2.3. Peptide synthesis and puriﬁcation
All peptides were synthesized manually following standard Fmoc-
solid phase protocols using Rink amide MBHA resin (Nova Biochem,
loading 0.56 mM/g) as solid support [19]. FITC labeled peptides were
synthesized by method described earlier [20]. Puriﬁcation of all the
peptides was performed on C-18 preparative RPHPLC column. The
RPHPLC analysis of peptides was performed on a Waters column
(4.6×250 mm, 300 Å, 5-μm particle size) with linear gradients of
water containing 0.05% TFA (gradient A) and acetonitrile containing
0.05% TFA (gradient B) at a ﬂow rate of 0.8 ml/min and with 1%
gradient B/min, starting at a concentration of 10% gradient B. After
puriﬁcation the correct peptide sequences were conﬁrmed by MALDI-
TOF (Kratos) mass determination and by automated peptide sequenc-
ing (490 Applied Biosystems). Characterization of the FITC labeled
peptides was done using SDS-PAGE methodology.
2.4. Antimicrobial activity
Antimicrobial susceptibility testing was carried out using a
modiﬁcation of the Clinical Laboratory Standard Institute (CLSI)
micro dilution broth assay [21]. Brieﬂy, the inoculums were prepared
from mid-logarithmic phase bacterial cultures. Each well of 96-well
polypropylene micro titre plate (SIGMA) was inoculated with 90 μl
of approximately 105 CFU/ml of bacterial suspension per ml of
Mueller-Hinton broth (HIMEDIA). Then 10 μl of serially diluted
peptides in 0.001% acetic acid and 0.2% bovine serum albumin
(SIGMA) over concentration ranging from 0.5 μg/ml to 512 μg/ml
was added to the wells of micro titre plate. The micro titre plates
were incubated overnight with agitation at 37 °C and after 18 h the
absorbance was read at 630 nm. Cultures (approximately 105 CFU/
ml) without peptide were used as positive control. Uninoculated
Mueller–Hinton broth was used as negative control. The tests were
carried out in duplicate. The minimum inhibitory concentration
(MIC) is deﬁned as the lowest concentration of peptide that
completely inhibits growth.
2.5. Bactericidal kinetics
The kinetics of bacterial killing of the peptides was evaluated
using E. coli (ATCC 11775) and S. aureus (ATCC 9144). Log-phase
bacteria (3×107 CFU/ml) were incubated with different peptides at
2×MIC of respective peptide in Muller Hinton media. Aliquots were
removed at ﬁxed time interval, diluted up to 108, plated on the MHA
agar plate and CFU were counted after 24 h incubation at 37 °C. Data
were obtained from two independent experiments performed in
duplicate.
2.6. Hemolytic activity
Hemolytic activity of the peptides was determined using human
red blood cells (hRBC). The hRBC were centrifuged for 15 min to
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buffer saline (35 mM phosphate buffer, 150 mM NaCl pH 7.2). One
hundred microliters of the hRBC suspended 4% (v/v) in PBS was
plated into sterilized 96-well plates and then 100 μl peptide solution
( serial twofold dilution in PBS) was added to each well. The plates
were incubated for 1 h at 37 °C without agitation and centrifuged at
1000g for 5 min. Aliquots (100 μl) of the supernatant were trans-
ferred to 96-well plates, where hemoglobin release was monitored
using ELISA plate reader (Molecular devices) by measuring the
absorbance at 414 nm. Percent hemolysis was calculated by the
following formula:
Percentage hemolysis = 100 A−A0ð Þ= At−A0ð Þ½ 
Where A represents absorbance of peptide sample at 414 nm and
A0 and At represent zero percent and 100% hemolysis determined in
PBS and 1% Triton X-100, respectively.
2.7. Proteinase K digestion assay
Proteinase-K digestion assay was performed using RP-HPLC as
described previously [22]. Digestion of peptides SA-1 and SA-4 as
representatives of gene encoded and non-gene encoded amino acid
containing peptides was carried out by treating 50 μg/ml of peptide
with 2 μg/ml Proteinase-K in 100 mM Tris buffer pH 7.6 at 25 °C. The
peptide cleavage after 30, 60, 90 and 120 min was monitored by HPLC
using C18 reverse phase column. Linear gradient of 0.1% aqueous TFA
and 0.1% TFA in acetonitrile were run. Absorbance was measured at
220 nm. Digestion was measured as percentage of degraded peptide
calculated from the decrease of the HPLC peak area of the native
peptide.
2.8. Tryptophan ﬂuorescence Blue shift
In the tryptophan ﬂuorescence blue shift experiment, small
unilamellar vesicles (SUVs) were used to minimize differential light
scattering effects [23]. Similar procedure was used for preparation of
SUVs as described earlier [24]. Brieﬂy dry lipids [DPPC/DPPG (7:3,w/w)
or DPPC/cholesterol (10:1, w/w)] were dissolved in chloroform/
methanol mixture in a small glass vessel. Solvent was removed by a
stream of nitrogen gas, so that a thin lipid ﬁlm was formed on the walls
of the glass vessel. The lipid ﬁlm thus obtained was then lyophilized
overnight. Dried thin ﬁlmswere re suspended in 10 mMTris–HCl buffer
[0.1 mM EDTA and 150 mM NaCl (pH 7.4)] by vortex mixing. The lipid
dispersionswere then sonicated in ice for 15–20min using titanium-tip
ultrasonicator with a burst and pulse time of 20 second and 5 second
respectively until the solution became opalescent. Titanium debris was
removed by centrifugation. Each peptide (ﬁnal concentration of 5 μM)
was added to 500 μl of 10 mM Tris buffer [0.1 mM EDTA and 150mM
NaCl (pH 7.4)] containing 0.5 mM liposome, and the peptide/liposome
mixture was allowed to interact at 20 °C for 2 min. The ﬂuorescence
measurementswere doneusing Fluoromax4 (spex) spectroﬂuorimeter.
Samples were excited at 280 nm, and the emission was scanned from
300 to 400 nm.
2.9. Preparation of LUVs for CD spectroscopy
CD spectroscopy analysis of peptides was done in buffer, helix
inducing solvent TFE (50% v/v) and bacterial mimic LUVs. LUVs were
prepared as described previously [25]. Brieﬂy desired mixtures of the
lipids DPPC: DPPG (7:3) was mixed in 2 ml chloroform/methanol
mixture in a 150-ml round bottom ﬂask. The solvent was removed
under a stream of nitrogen and the lipid ﬁlm obtainedwas lyophilized
overnight to remove any trace of solvent. The thin lipid ﬁlm was
rehydrated with 10 mM sodium phosphate buffer, vortex mixed for
half an hour on a water bath kept above the phase transitiontemperature of the lipid mixture. The multilamellar vesicles thus
obtained were extruded 16 times through a 100 nm polycarbonate
membrane extruder (Avanti mini extruder apparatus). Mean diam-
eter of LUVs was determined by dynamic light scattering, using a
Zetasizer Nano ZS (Malvern Instruments, Malvern, UK). Mean
diameter of LUVs was found to be in the range of 110–115 nm.
2.10. C D spectroscopy
The Circular Dichroism (CD) spectra of the peptides were recorded
using a Jasco J-715 CD spectrophotometer (Tokyo, Japan) with a 1 cm
path length cell. Wavelengths from 200 to 260 nm were scanned with
1.0 nm step resolution, 100 nm/min speed, 0.4 second response time,
and 1 nm bandwidth. CD spectra of the peptides were collected and
averaged over two scans in 10 mM sodium phosphate buffer (pH 7.2),
helix inducing solvent TFE 50% (v/v) and bacterial mimic LUVs( 680 μM
lipid). Spectra were baseline corrected by subtracting a blank spectrum
containing only buffer or LUVs. The spectra were expressed as ellipticity
[θ] vs. wavelength.
2.11. Calcein dye leakage assay
In order to assess ability of the designed peptides to cause leakage
of liposomal content, LUVs composed of bacterial mimic membrane
(DPPC:DPPG, 7:3, w/w) or mammalian mimic membrane (DPPC/
Chol, 10:1, w/w) were used. LUVs were prepared as described in
section 2.9 except the dry lipid ﬁlms were rehydrated with 10 mM
Tris–HCl [70 mM calcein, 150 mM NaCl, 0.1 mM EDTA]. After addition
of calcein, pH of the LUVs mixture drop down, to make it up to 7.2 a
few drops of sodium hydroxide solution (1 M) were added. The
liposome suspension obtained after rehydration was freeze thawed
for ﬁve cycles and extruded 16 times through two stacked
polycarbonate ﬁlters (100 nm pore size). The free calcein was
removed by passing the liposome suspension through a Sephadex
G-50 column at 23 °C and eluting with a buffer containing 10 mM
Tris–HCl [150 mM NaCl, 0.1 mM EDTA]. After passing the liposome
through Sephadex G-50, liposome diameter was measured by
dynamic light scattering using a Zetasizer Nano ZS (Malvern
Instruments). Average diameter of LUVs was found to be in the
range of 110–130 nm. Leakage of calcein from the LUVs was
monitored by measuring the ﬂuorescence intensity at an excitation
wavelength of 490 nm and an emission wavelength of 520 nm on a
model Fluoromax 4 (spex) spectroﬂuorimeter. Different concentra-
tions of peptides were incubated with bacterial mimic liposome for
5 min before exciting the samples. For comparison indolicidin was
used as a standard peptide. For the determination of 100% dye
leakage 1% Triton X-100 (20 μl) in 10 mM Tris–HCl buffer [150 mM
NaCl, 0.1 mM EDTA] was added to dissolve the liposome. The
percentage of dye leakage caused by the peptides was calculated
using the formula
Dye leakage %ð Þ = 100 F−F0ð Þ= Ft−Fð Þ½ 
Where F is the ﬂuorescence intensity achieved by the peptides and
F0 and Ft are ﬂuorescence intensities in buffer and with Triton X-100,
respectively. All measurements were made in triplicate. Phosphate
assay was performed with the lipid mixture to determine the exact
concentration of lipids for the leakage experiment [26].
2.12. Transmission electron microscopy
Large unilamellar vesicles for TEM analysis were prepared in a
similar fashion as has been described in section 2.9. [DPPC/DPPG (7:3,
w/w)] was used as model membrane representing bacterial mimic
membrane. Peptide SA-3 or SA-4 were incubated (for 30 min) with
LUVs at 25 °C in 10 mM sodium phosphate buffer at a peptide
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suspension was applied to glow-discharged carbon-coated copper
grids for 1 min. The grids were rinsed in the same buffer, and stained
with 2% PTA. Electron micrographs were then recorded using FEI
Morgagni 268(D) operated at 70 kV.2.13. Scanning electron microscopy
E. coli (ATTC 11775) cells were suspended at 108 CFU/ml in 10 mM
PBS, pH 7.4 supplemented with 100 mM NaCl, and incubated at 37 °C
with peptides SA-3 or SA-4 at 10× MIC. Controls were run in the
absence of peptides. After 30 min the cells were ﬁxed with an equal
volume of 4% glutaraldehyde in 0.2 MNa-cacodylate buffer, pH 7.4, for
3 h at 4 °C followed by dehydration with graded series of ethanol and
dried the sample in HMDS (hexamethyl disilazane). Coating was done
with gold approximately 20 nm thicknesses and observed under
scanning electron microscope (Leo 435 VP).2.14. Confocal laser scanning microscopy
E. coli (ATCC 11775) cells inmid-logarithmic phasewere harvested
by centrifugation, washed three times with phosphate buffer saline
10 mM, pH 7.3. E. coli (107 CFU/ml) cells were incubated with FITC
labeled peptides SA-3 or SA-4 at 5 μg/ml and 10 μg/ml at 37 °C for
30 min (MIC of FITC tagged peptides was evaluated against E. coli cells,
no effect was observed on MIC of peptide SA-3 whereas for peptide
SA-4 there was a twofold increment in the MIC value). After being
incubated, the bacterial cells were palleted down and washed 3 times
with 10 mM sodium phosphate buffer and immobilized on a glass
slide. The FITC-labeled peptides were observed with a Zeiss Axioplan
2 optical microscope (Japan). Fluorescent images were obtained with
a 488 nm band-pass ﬁlter for excitation of FITC.2.15. Flow cytometry
E. coli ATCC 11775 was grown to mid log phase in Mueller-Hinton
broth (HIMEDIA), washed thrice with buffer (10 mM Tris, pH 7.4) and
resuspended in buffer to obtain 2×108 CFU/ml bacterial suspension.
The bacterial suspension was diluted to 105 CFU/ml in the same
buffer. Different peptide concentrations (2.5 μg/ml, 5 μg/ml and
10 μg/ml) were incubated with 1 ml of bacterial suspension at ﬁxed
PI concentration of 10 μg/ml for 15 min. A FACS ﬂow cytometer
(Guava Technologies, Hayward, CA, USA) was used to obtain the data
with a wavelength of laser excitation 488 nm. Data were analyzed by
Express plus cytosoft software (Guava Technologies, Hayward, CA,
USA).Table 1
Name, sequence, molecular mass, percentage purity and mean hydrophobicity of the
designed peptides.
Peptide Sequence Molecular Mass % purity
(HPLC)
M.H.d
Calc. Obs.
SA-1 IKWAGKLFKLFK-NH2 1476.8 1499.0c b95 1.2
SA-2 IKPAGKLFKLFK-NH2 1388.8 1389.9b b95 0.3
SA-3 IKWAGKWWKLFK-NH2 1589.9 1589.9a b98 1.2
SA-4 IOWAGOLFOLFO- NH2 1421.7 1422.0b b95 1.5
SA-5 IOWAGOWWOLFO-NH2 1533.9 1555.5c 91.7 1.5
SA-6 AcIKWAGKWWKLFK- NH2 1632.9 1645.0c b98 1.2
ILe ILPWKWPWWPWRR-NH2 1906.0 1906.0a b98 0.2
a[M+] peak; b[M++1] peak; c[M++Na].
dMean hydrophobicity calculated using consensus scale.
eIndolicidin.2.16. DNA-binding assay
Gel retardation experiments were performed for peptide SA-3, SA-
4 and indolicidin (as a standard) as described previously [13]. Brieﬂy
100 ng of the plasmid DNA (pBluescript II SK+) was mixed with
increasing amounts of peptide in 20 μl of binding buffer (5% glycerol,
10 mMTris–HCl, pH 8.0, 1 mMEDTA, 1 mMdithiothreitol, 20 mMKCl,
and 50 μg/ml bovine serum albumin). Reaction mixtures were
incubated at room temperature for 1 h. Subsequently, 4 μL of native
loading buffer was added (10% Ficoll 400, 10 mM Tris–HCl, pH 7.5,
50 mM EDTA, 0.25% bromophenol blue, and 0.25% xylene cyanol), and
a 20-μl aliquot subjected to 1% agarose gel electrophoresis in 0.5×Tris
borate–EDTA buffer (45 mMTris–borate and 1 mMEDTA, pH 8.0). The
plasmid DNA was purchased from Stratagene and was used as such
without further puriﬁcation.3. Results
3.1. Peptide design and biological activities
In the present study we undertook design and synthesis of
membrane active peptides rich in Trp and Lys residues with a template
of 12 amino acid residues H+HHG+HH+HH+NH2 (where H:
hydrophobic amino acid and +: charged hydrophilic amino acid
residue), +5 charge and an amidated C-terminal. Name, sequence,
molecularmass, percentage purity byHPLC andmeanhydrophobicity of
the designed peptides has been presented in Table 1. Using key amino
acid residues such as Pro and Trp changeswere done at the hydrophobic
positions of the template. At the charged hydrophilic positions in the
template Lys residues were replaced with Orn residues. In accordance
with Antimicrobial Peptide Database, usingminimalist approach amino
acid residueswithmaximumpropensity to be present in CAMPs such as
glycine, lysine, alanine, isoleucine, phenylalanine and tryptophan were
used. Based on a common template of hydrophobic and hydrophilic
amino acid residues initially three peptides (SA-1, SA-2 and SA-3) were
generated. Secondary structure prediction tools available online
(Antimicrobial peptide database) and SCRATCH servers (Cheng et al.
2005; http://www.igb.uci.edu/tools/scratch) predicted helical struc-
ture for peptide SA-1. In peptide SA-2 changes were done in the
hydrophobic segment of the peptide SA-1 where Trp at position 3 was
replacedwith Pro (single amino acid substitution) a helix breaker imino
acid. It is well known that Trp-rich peptides have enhanced membrane
binding properties [27]. For the synthesis of a Trp-rich peptide, in
peptide SA-3 two Trp residues were placed adjacent at position 7 and
8 replacing Leu and Phe in peptide SA-1 respectively. Non-gene encoded
amino acidOrnwasused asapositively charged residue inplace of Lys to
impart proteolytic stability to designed peptides. In peptide SA-4 all Lys
residues of SA-1were replacedwith Orn, in peptide SA-5 all Lys residues
of SA-3 were replaced with Orn. SA-6 is acetylated analogue of SA-3.
AcetylationofN-terminus of leadpeptideSA-3wasdone to see theeffect
of acetylation on antimicrobial activity, selectivity and induced structure
in model membranes.
Antimicrobial activity of designed peptides was tested against two
Gram-positive (S. aureus and B. subtilis), two Gram-negative (E. coli
and P. aeruginosa) and two clinical bacterial isolates (Acenatobacter
spp. and E. coli) Table 2. Peptide SA-1, which is ideally amphipathic
exhibited potent antimicrobial activity against all bacterial strains
studied. Peptide SA-2 exhibited a poor efﬁcacy at killing all the Gram-
negative and Gram-positive bacterial strains with MIC in the range of
64–512 μg/ml. Peptide SA-3 showed 2 to 4 times better potency at
killing the bacterial strains as compared to peptide SA-1. It was
interesting to see that the antimicrobial activities of peptide SA-4 or
SA-5 were not modiﬁed to a great extent by incorporation of Orn
residue. Acetylated derivative of lead peptide SA-3 was also found to
be almost equally active in comparison to peptide SA-3. Major thrust
of these peptides is their ability to check growth of multi-drug-
Table 2
Antibacterial activity of designed peptides against susceptible as well as clinically
resistant bacterial strains.
Peptide MIC( μg/ml)
Gram negative
bacteria
Gram positive
bacteria
Gram negative clinical
isolatesa
E. coli P. aeruginosa B. subtilis S. aureus Acenatobacter sp. E. coli
SA-1 1 8 8 4 32 4
SA-2 ND b512 b512 512 64 512
SA-3 1 1 4 2 16 1
SA-4 4 8 8 16 16 4
SA-5 2 ND 4 ND 8 1
SA-6 1 1 4 ND 4 2
Indolicidin 32 16 32 16 64 8
a Clinical isolates used in the present study were collected from All India Institute of
Medical Sciences, New Delhi, India. Antibiotics against which the clinical isolates were
found to be resistant were amikacin, netilmicin, ciproﬂoxacin, cefoparazone, piper-
acillin, piperacillin-tazobactam, imipenem and cefotaxim.
1868 S. Joshi et al. / Biochimica et Biophysica Acta 1798 (2010) 1864–1875resistant clinical isolates in the concentration range of 1–32 μg/ml. In
comparison to designed template based peptides (except SA-2)
standard peptide indolicidin was found to be less potent at killing
bacterial strains used in the present study.
Viability of exponentially growing E. coli and S. aureus as
representative Gram-negative and Gram-positive bacterial strains
was checked against peptides SA-1, SA-3 and SA-4 by time-kill assay.
The time kill curves of peptide SA-1, SA-3 and SA-4 against S. aureus
are shown in Fig. 1A and against E. coli in Fig. 1B. With a rapidFig. 1. Bactericidal kinetics of peptides SA-1, SA-3 and SA-4 at 2×MIC. (A) Bactericidal
kinetics of peptides against S. aureus. (B) Bactericidal kinetics of peptides against E. coli.
Peptides are represented as ( ) SA-1, ( ) SA-3 ( ) SA-4 and ( ) control no
peptide. Data obtained are from two independent experiments performed in duplicate.
Error bars were too narrow to display.bactericidal kinetics peptide SA-1 reduced CFU/ml of S. aureus by 2
Log-CFU/ml within 30 min of incubation period at 2× MIC. Most
active peptide SA-3 could completely eradicate 107 CFU/ml of S.
aureus at 2×MIC over a period of 1 hwhereas peptide SA-4 took 2 h to
completely eradicate 107 CFU/ml. In accordance with MIC data
peptide SA-3 exhibited rapid killing rate against E. coli causing almost
5 log unit reductions in CFU/ml over a period of 30 min and complete
killing activity within 1 h. Peptide SA-1 also caused signiﬁcant
reduction in CFU/ml of E. coli within 30 min however it took 90 min
to remove complete growth. Peptide SA-4was less rapid in its mode of
action and could never eradicate complete growth over a period of 2 h
(Fig. 1B).
To analyze stability imparted to peptides by incorporation of Orn
residues we compared time course analysis of percentage digestion of
peptides SA-1 and SA-4 with Proteinase-K. Data are represented in
the form of percentage degradation of peptides against time by
measuring area under the major peak in RPHPLC chromatogram of
Proteinase-K treated peptides (Fig. 3). As the digestion data suggest,
both the peptides SA-1 and SA-4 (all Orn analog of SA-1) showed
almost 25% digestion within a period of 30 min after incubation with
Proteinase-K. There on percentage digestion of SA-1 increases rapidly
leading to 78% digestion in 2 h whereas peptide SA-4 is digested to
51% of total peptide content. The data suggest incorporation of Orn
into the sequence of SA-1 enhances proteolytic stability of the
peptides to some extent.
3.2. Selectivity of designed peptides for bacterial membranes over
mammalian membranes and induced secondary structure
Hemolytic activity of the synthetic peptides was studied as a
measure of toxicity against human erythrocytes. 1% Triton-X 100 was
used for complete hemolysis. Results of hemolytic activity are
presented in Fig. 2. Peptide SA-1 was found to be hemolytic among
all the peptides designed. Peptide SA-1exhibited 85% hemolysis of
hRBC at 512 μg/ml. Interestingly when all Lys of SA-1 were replaced
by Orn (SA-4), drastic reduction in hemolytic activity was observed. It
seems that whereas replacement of Lys with Orn has no appreciable
effect on antimicrobial activity of the designed peptides, it certainly
had a remarkable effect on the hemolytic activities of the designed
peptides. Peptides SA-2, SA-3, SA-4 and SA-5 were non-hemolytic upFig. 2. Dose–response curves of hemolytic activity of the designed peptides against
human erythrocytes. Different concentrations of peptides were incubated with 4% hRBC
suspension for 1 hr at 37 °C. After 1 h of incubation, hemoglobin release from the
ruptured hRBC was studied by measuring absorbance at 414 nm. For complete lyses 1%
Triton X-100 was taken as positive control and for no lyses PBS as negative control.
Peptides are indicated as follows: ( ) SA-1, ( ) SA-2, ( ) SA-3, ( ) SA-4,
( ) SA-5, ( ) SA-6 and Indolicidin (×).
Fig. 3. Percentage degradation of peptides ( ) SA-1 and ( ) SA-4 with
Proteinase-K at 25 °C using RP-HPLC.
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512 μg/ml. Indolicidin was found to cause damage to the hRBC from a
low concentration of 64 μg/ml and caused almost 87% hemolysis up to
512 μg/ml.
To analyze environment of Trp residue(s) of peptides in model
membranes, SUVs of representative compositions were used. Trp
ﬂuorescence spectra of peptides SA-1 to SA-6 (except SA-2) and
indolicidin (as a standard peptide) were recorded in 10 mM Tris
buffer (0.1 mM EDTA and 150 mM NaCl, pH 7.4) or in the presence of
vesicles composed of either zwitterionic phospholipids [DPPC/
Cholesterol (10:1, w/w) SUVs] or negatively charged phospholipids
[DPPC/DPPG (7:3, w/w) SUVs]. In buffer the emission maxima for all
the peptides was found to be in the range of 355–360 nm. In
negatively charged vesicles, single Trp containing peptides SA-1 and
SA-4 showed large blue shifts in the emission maxima of Trp residue
(Table 3). Relatively lower as compared to peptide SA-1 and SA-4 and
almost comparable blue shifts were observed for peptides SA-3, SA-5,
SA-6 and indolicidin in bacterial mimic SUVs. Maximum blue shift in
emission maxima was observed for peptide SA-1 (28 nm). A blue
shift of 14 nm observed for indolicidin in bacterial mimic membrane
which is in accordance with the literature [13]. In mammalian mimic
SUVs a blue shift in the range of 3–10 nm was observed for all the
peptides, which is very less as compared to blue shift in bacterial
mimic membranes. In order to elucidate secondary structure of
peptides, CD spectra of peptides in buffer, helix inducing solvent TFE
(50%, v/v) and bacterial mimic LUVs was acquired. Results of CD
experiment for peptide SA-1 to SA-6 are presented in Fig. 4. CD
spectra of peptides in 10 mM sodium phosphate buffer (pH 7.2) are
random coil for peptide SA-1, SA-2, SA-3 and SA-4 showing minima
in the range of 202–212 nm for the peptides. For peptide SA-5 inTable 3
Tryptophan Emission Maxima of the Peptides in 10 mM Tris–HCl buffer [0.1 mM EDTA
and 150 mM NaCl (pH 7.4)] or in the presence of DPPC/DPPG (7:3, w/w) SUVs and
DPPC/Chol (10:1, w/w) SUVs.
Peptide Buffer
(nm)
DPPC/DPPG
(7:3, w/w) (nm)a
DPPC/Chol
(10:1, w/w) (nm)a
SA-1 355 327 (28) 348 (7)
SA-3 356 338 (18) 346 (10)
SA-4 358 332 (26) 350 (8)
SA-5 359 343 (16) 357 (3)
SA-6 360 346 (14) 359 (4)
Indolicidin 357 343 (14) 349 (8)
a Blue shift in emission maxima in parentheses.buffer a negative band at 218 nm and a positive band at 204 nm was
observed. For peptide SA-6 in buffer a minimum at 240 nm and a
positive band at 212 nm was obtained. Although in 50% TFE peptide
SA-1 and SA-4 are unable to gain a helical structure these two
peptides were able to acquire helical conformation in the presence of
bacterial mimic LUVs with double minimum at 208 nm and 222 nm.
[28]. For peptide SA-4 in bacterial mimic membrane the general
curve similar to the canonical structure of an alpha helical peptide
was obtained, however the band at 208 nm was slightly shifted to
higher wavelength.CD spectra of peptides SA-2 exhibited some
ordering in bacterial mimic LUVs though not helical in particular. In
bacterial mimic LUVs peptides SA-3 and SA-5 exhibited a deep
minimum in the range of 230–232 nm typically representing
aromatic stacking of two adjacent Trp residues at position 7 and
8 of the peptides [29]. For peptide SA-6 in bacterial mimic LUVs a
minima at 231 nm and positive bands at 222, 217 and 212 nm can be
attributed to aromatic stacking (negative band) as well as turn
structure [30].3.3. Peptide–lipid interactions using model membranes
Further for comparing membrane interactions of a template based
peptide SA-1 and SA-4 with selective Trp-rich peptide SA-3 we
studied the ability of the peptides to cause membrane leakage by
testing their ability to evoke calcein release from LUVs made from
negatively charged and zwitterionic phospholipids. For the study,
calcein encapsulated LUVs were used at a concentration of 70 mM
calcein, a concentration at which ﬂuorescence of calcein is self-
quenched. Upon treatment of calcein encapsulated LUVs with
peptides if the peptide is able to break the liposomal shell thereby
leading to outburst of calcein into the aqueous environment, the dye
starts ﬂuorescing and thus the ﬂuorescence signal intensity increases.
Data were obtained after equilibrating the samples for 5 min after
peptide addition to obtain stable ﬂuorescence values. The dose–
response curves of peptide-induced calcein release are shown in
Fig. 5. Peptide SA-1 caused maximum leakage of calcein dye up to 76%
at the maximum concentration tested. The order for the relative
extent of calcein leakage from negatively charged vesicles was SA-1,
SA-3, indolicidin and SA-4. On comparing leakage proﬁle of peptide
SA-3 and SA-4 from bacterial mimic LUVs [DPPC:DPPG, 7:3,w/w] it is
evident that peptide SA-3 caused a graded release of calcein dye
which starts at a low concentration and thereafter remains constant
up to themaximum concentration tested of 5.5 μg/ml. For peptide SA-
4 as the concentration increases a sharp increase in leakage of
encapsulated calcein dye was observed.Calcein leakage data end in
plateaus for all three peptides except peptide SA-4. Leakage data with
mammalian mimic DPPC: chol (10:1, w/w) with all the peptides at
the maximum exhibited up to 11% leakage of calcein dye at the
highest concentration of 8.8 μg/ml tested (data not presented here).
Leakage data for indolicidin included as a standard peptide in the
study correlates well with earlier reports on low leakage inducing
potential for the peptide [25].
Knowing the peptides are acting on the surface of bacterial
membrane TEM studies were conducted with peptide SA-3 or SA-4 at
a concentration of 10 μg/ml with LUVs composed of (DPPC: DPPG, 7:3
w/w) bacterial mimic membranes. TEM studies were conducted to
visualize effect of peptides on the model membranes and the results
showed surface alterations of the liposome. To ensure validity of
images obtained as a result of peptide liposome interaction only
separate copper grids were used to reproduce the results with the
same sample. Peptide SA-3 caused deformation of the surface of the
liposome making pores or channels in the surface of the liposome
(Fig. 6B). Earlier reports in literature have reported aggregation
of negatively charged vesicles or deformation of liposome as a result
of lipid peptide interaction [31]. Peptide SA-4 treated liposomes
Fig. 4. CD spectra of designed peptides. In ﬁgure (A), SA-1, (B) SA-2, (C) SA-3, (D) SA-4, (E) SA-5 and (F) SA-6. Spectra recorded in (○) 10 mM sodium phosphate buffer, (●) in
presence of 50% TFE (v/v) and (▲) in bacterial mimic LUVs. Peptide and lipid concentrations were 50 μM was 680 μM respectively.
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content (Fig. 6C).3.4. Surface disruption and internalization of designed peptides in E. coli
ATCC 11775 along with a comparative DNA binding assay
Extending our study from model membranes to intact E. coli ATCC
11775 we visualized morphological alterations of peptide on E. coli
cells. E. coli cells treated with peptides at 10×MIC were visualized.
Untreated E. coli cells exhibited bright and smooth surface (Fig. 7A).
Upon treatment of E. coli cells with peptide SA-3 at 10 × MIC well
deﬁned pores could be visualized on the surface of bacterial cell
(Fig. 7B). On the other hand on treatment of E. coli with peptide SA-4
surface blebs were spotted on the surface of E. coli (Fig. 7C). It wasFig. 5. Concentration-dependent leakage of calcein dye fromnegatively charged [DPPC⁄
DPPG (7:3, w/w)] LUVs at pH7.2measured after 5 min of incubation of different peptide
concentration with LUVs. Peptides are indicated as follows: ( ) SA-1, ( ) SA-3,
( ) SA-4 and ( ) Indolicidin.evident from the SEM data that peptide SA-3 and SA-4 take up two
different patterns of membrane perturbation.
For the determination of site of action of the designed peptides,
FITC-labeled peptides SA-3 and SA-4 were incubated with log phase E.
coli ATCC 11775 and their localization was visualized by confocal
laser-scanning microscopy. E. coli cell treated for half an hour with
FITC labeled peptide SA-3 (5 μg/ml) at room temperature appeared as
green rods with ﬂuorescence spread throughout the bacterial cell
indicating internalization of FITC-labeled peptides into the cytoplasm
of the bacteria (Fig. 8B). It was observed that peptide FITC-SA-4 was
able to traverse bacterial membrane at 10 μg/ml concentration along
with cell damage and was unable to translocate at low concentration
(Fig. 8D and E). Confocal data suggest that peptide SA-4 needed a
threshold concentration to traverse into the bacterial membranes.
Using a bacterial cell density of E. coli (ATCC 11775) in the range of
105, ﬂow cytometric analysis was performed to understand the
concentration dependent internalization potentials of the lead
peptides SA-3 and SA-4. In ﬂow cytometric analysis permeability of
a DNA intercalating dye propidium iodide into the compromised cell
membrane of E. coliwas studied. In the experiment as negative control
E. coli ATCC 11775 cells were incubated with PI without any test
peptide. For permeabilization monitoring E. coli ATCC 11775 was co-
incubated with various peptide concentrations (2.5, 5, 10 μg/ml) at a
ﬁxed concentration of PI (10 μg/ml). Bovine indolicidin with well-
deﬁned non-membrane perturbing mode of action was included in
the study as a reference peptide. Results of the experiment are
presented in Fig. 9. Rapid increase in PI ﬂuorescence was observed for
peptide SA-3 at 5 μg/ml (29% cells stained with PI) however peptide
SA-4 caused only minimal increase in the ﬂuorescence at 5 μg/ml. At
10 μg/ml peptide SA-3 was able to cause rapid increase in PI
ﬂuorescence with 86% cells stained with PI. For peptide SA-4 at
10 μg/ml only 20% cells were stained with PI. According to the data
indolicidin was unable to traverse the bacterial membranes up to
10 μg/ml with only 7% cell stained with PI.
To explore intracellular targeting mechanisms we compared the
DNA binding afﬁnity of the two peptides SA-3 and SA-4 (Fig. 10). The
gel retardation assay was examined by analyzing the electrophoretic
mobility of DNA bands at various ratios of peptide to DNA on a 1%
Fig. 6. Transmission electron micrograph of peptide treated LUVs composed of bacterial mimic membrane. Untreated liposome in Figure (A), liposome treated with peptide SA-3
(10 μg/ml) for 30 min (B) liposome treated with peptide SA-4 (10 μg/ml) for 30 min(C).
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starting from a concentration of 5 μg/ml whereas indolicidin started
retardation at a concentration of 10 μg/ml and SA-4 retarded DNA
movement to a much lesser extent after 20 μg/ml.
4. Discussion
Design of antimicrobial peptides based on sequence analogy and
amphipathicity has been exploited widely by different research
groups to design novel antimicrobial peptides [32,33]. In the present
study based on minimalist template approach we obtained short and
potent CAMPs with activity against a number of bacterial strains
including Gram-positive, Gram-negative and multidrug-resistant
Gram-negative bacterial strains. In order to clarify mode of action of
designed peptides (SA-1 to SA-6), peptide–lipid interactions includ-
ing structure acquisition propensity and assessment of environment
of Trp residue were carried out using model membranes. Based on
these results and toxicity (measured in terms of hemolytic activity)
proﬁles of the peptides, we further aimed to have insight into the
detailed mode of interaction of peptides SA-3 and SA-4 with model
membranes as well as E. Coli ATCC 11775. For Trp-rich peptide SA-3
rapid membrane translocation along with transient pore formation
(as evidenced by calcein leakage) was observed at low concentrations
implying role of intra cellular targeting as mode of action (which was
also corroborated by better DNA binding afﬁnity) whereas for
template based peptide SA-4 a high concentration verge was
obligatory to exhibit membrane translocation though membrane
perturbation was evident at lower concentrations.
All the peptides designed in the present study based on an
amphipathic template of 12 residues showed potent antimicrobial
activity against the bacterial strains tested except peptide SA-2. The
observed decrease in antibacterial potencymay be correlatedwith the
decreased hydrophobicity of peptide SA-2 resulting from removal ofFig. 7. Scanning electron microscopic images of E. coli (ATCC 11775) treated with peptides. E
with SA-4 at 10×MIC for 30 min (C). The bar in the image represents 1 µm.Trp residue at third position and a loss of secondary structure
acquisition tendency in membrane bound state due to incorporation
of Pro residue. Trp residue which has a tendency to position itself at
the interface between the lipid layer and the polar head groups has
been reported to enhance membrane interactions and thus we
observed a deleterious effect of replacing Trp with Pro residue on
antimicrobial activity and secondary structure acquisition tendency.
In literature also it has been reported that placement of certain Trp
residues at key positions can be crucial for better antimicrobial
potency [34]. Trp-rich peptides are more potent at membrane
interaction was further corroborated by potent activity of Trp-rich
peptides SA-3, SA-5 and SA-6 designed in the study.
CAMPs have gained much attention in the past decade because of
their rapid killing mechanism and wide spectrum of activity against
bacteria, fungi, virus, protozoa and cancerous cell. Bactericidal kinetics
data of the peptides indicated that at 2×MIC peptides SA-1, SA-3 and
SA-4 were able to cause signiﬁcant damages to E. coli and S. aureus
cells within 15 min of incubation (Fig. 1). Comparison of Proteinase-K
stability data based on RPHPLC of peptide SA-1 and SA-4 showed
better in vitro stability for Orn containing peptide SA-4 as compared
to SA-1 (Fig. 3).
For systematic use as a therapeutic agent it is important to develop
potent CAMPs with less toxicity against host cells. In our study
hemolytic activity as ameasure of host cell toxicity showed that out of
the six peptides designed peptide SA-1 was found to be hemolytic
against hRBC. Interestingly in peptide SA-4 where all Lys residues of
peptide SA-1 have been replaced with Orn residues exhibited
negligible hemolytic activity. As the two peptides SA-1 and SA-4
differ only in the depth of their polar sector, determined by length of
the side chain of charged polar residues Orn and Lys, in concord with
earlier literaturewe propose better insertion of Lys containing peptide
SA-1 into the hydrophobic bulk of hRBC that might lead to hemolytic
activity. The better insertion/penetration depth of Lys containing. coli untreated (A), E. coli treated with SA-3 at 10×MIC for 30 min (B) and E. coli treated
Fig. 8. Confocal Laser scanning microscopic images of peptide treated E. coli 11775 cells at different concentrations. Untreated E. coli cells in ﬁgure (A), E. coli treated with peptide
FITC-SA-3 at 5 μg/ml (B), E. coli treated with FITC-SA-3 at10 μg/ml (C), E. coli treated with peptide FITC-SA-4 at 5 μg/ml (D), E. coli treated with peptide SA-4 at 10 μg/ml (E). For each
treatment ﬂuorescence and DIC images have been presented.
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correlated with snorkling effect whereby longer side chain of Lys
residues tend to stretch towards the membrane interface thus leading
to deeper penetration in the membrane bilayer [35]. The better
membrane interactions of peptide SA-1 were also evident from CD
spectra of the two peptides where the induced helical structure was
much pronounced for peptide SA-1 as compared to peptide SA-4.
Peptide SA-3 and SA-5 were relatively less effective at perturbing
hRBCs both showing negligible hemolytic activity. On comparing Orn
containing peptides SA-4 and SA-5 it was observed that both the
peptides exhibit a shallow insertion into human erythrocytes which
was reﬂected by their low hemolytic activity however the better
potency of peptide SA-5 in comparison to SA-4 can be ascribed to
presence of multiple Trp residues. Peptide SA-6 (acetylated analogue
of peptide SA-3) exhibited 30% hemolytic activity at 512 μg/ml
(Fig. 2). The probable explanation for this increase in hemolytic
behavior of peptide SA-6 can be accounted by taking into consider-
ation the fact that acetylation of N-terminus removes one unit positive
charge from the N-terminal of the peptide SA-6 altering the positive
charge distribution of peptide SA-6 in such a way that might facilitate
better folding and penetration of Trp residue at position 3 into the
hydrophobic bulk of zwitterionic membranes. This induced folding
would allow peptide SA-6 to better assume a wedge like structure as
has been observed in the present study and has also been reported for
Trp-rich peptides indolicidin and tritripticin[27]. Further tryptophan
ﬂuorescence studies substantiated the membrane discriminatory
activities of the designed peptides on model membranes. A blue
shift in the emission maxima of Trp residues suggests insertion of Trp
residues into the hydrophobic environment of bacterial mimic
membrane resulting because of preference of Trp residue to locate
itself at membrane interface rather than in aqueous environment. As
compared to buffer, large blue shift values for emissionmaxima of Trp
residue were observed for all six peptides in bacterial mimic
membranes (DPPC:DPPG, 7:3, w/w) (Table 3). The maximum blueshift observed for peptide SA-1 indicated maximum burial of Trp
residue of peptide SA-1 into the core of bacterial mimic membranes.
The relatively lower blue shift observed can be ascribed to presence of
multiple Trp residues in these peptides [36]. On comparing environ-
ment of Trp residues in Trp-rich peptides SA-3, SA-5 and SA-6, though
almost comparable blue shifts were observed in the range of 14–
16 nm, the relative order of quantum yield for the peptides in
bacterial mimic membrane was SA-3NSA-6NNSA-5 whereas in
mammalian mimic membrane the order was altered to SA-6NSA-
3NNSA-5 (data not presented here). These results are indicative of a
more restricted environment of Trp residues in mammalian mimic
membrane for peptide SA-6 that accounts for the slight toxicity of
peptide SA-6. In mammalian mimic membrane (DPPC: Chol) lesser
blue shift was observed for all the peptides. The lesser blue shift
observed (3–10 nm) for all six peptides in mammalian mimic
membrane (DPPC: Chol) can be accounted by taking into consider-
ation the lesser preference of Trp residue (of the cationic peptide) to
insert into zwitterionic DPPC membrane which gets further rigidiﬁed
upon inclusion of cholesterol. It has been reported that cholesterol
causes a reduction of the density of the head group in DPPC at the
interfacial region of the bilayer and an increase in the package of the
phospholipid tails in the middle of the bilayer making insertion of Trp
residue less likely [37]. CD spectra of peptides SA-1 and SA-4 in
bacterial mimic LUVs showed a propensity to acquire helical
conformation whereas peptides SA-2 also exhibited some ordering
in TFE and bacterial mimic LUVs. Peptide SA-3, SA-5 and SA-6 were
practically devoid of helical propensity due to presence of two
adjacent Trp residues at 7 and 8 positions. For these three peptides SA-
3, SA-5 and SA-6 the minima at 226–232 nm has typically been
assigned to Trp-Trp stacking in small peptides [38]. In addition for
peptide SA-6 positive bands at 222, 217 and 212 indicated a turn
structure for peptide SA-6. Although CD data are not sufﬁcient to
comment on the secondary structure but in analogy to other Trp-rich
CAMPs (like Indolicidin and tritripticin) maybe the peptide SA-6
Fig. 9. Effect of peptide SA-3, SA-4 and indolicidin on membrane integrity and viability of E. coli. Bacteria (1×105 CFU/ml) were incubated for 15 min with SA-3 (A-C) or SA-4 (D-F)
or indolicidin (G-I) at 2.5, 5 and 10 μg/ml in MH broth respectively and was subjected to ﬂow cytometry study. Background values obtained with untreated samples (b1.78% of
permeabilized cells) were subtracted from each peptide-treated sample. Events (5000) were counted for each experiment.
Fig. 10. Gel retardation assays. Binding was assayed by the inhibitory effect of peptides on the migration of DNA bands. Various amounts of peptides were incubated with 100 ng of
plasmid DNA at room temperature for 1 h and the reaction mixtures were applied to a 1% agarose gel electrophoresis. Lane 1, plasmid DNA, lane2, 2.5 μg/ml peptide, lane 3, 5 μg/ml,
lane 4, 10 μg/ml, lane 5, 20 μg/ml, lane 6, 40 μg/ml.
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as has been characterized by aminima at 228 nm for tritripticin which
binds the membranes in a wedge like manner. [27] (Fig. 4).
Like many other membrane permeabilizing CAMPs such as LL-
37 and melittin peptides designed in the present study showed a
graded release of encapsulated ﬂuorescent dye calcein [39,40].
Only partial leakage of vesicle contents caused by peptides SA-3
and SA-4 can be justiﬁed based on graded leakage mechanism
which is suggestive of the fact that the peptides might have pore
formation as a subsidiary mode of action and the leakage observed
was actually a result of mass imbalance caused by binding of the
peptide to the membrane. As soon as the peptide translocation is
over the transient pore formed gets closed and no further leakage
is observed [41]. Peptide SA-1 with better membrane binding
abilities started the interaction/translocation at low concentration
whereas for peptide SA-4 a concentration threshold was required
to induce leakage and translocation. We further carried out TEM
study using bacterial mimic LUVs to gain visual evidences for
membrane lipid interactions. In earlier TEM reports on various
CAMPs, peptides induced aggregation or deformation of vesicles
has been reported as a result of peptide lipid interactions [42]. We
observed a smooth spherical lipidic vessel that gets distorted as a
result of peptide lipid interactions. For peptide SA-3 we could
visualize transient openings that could have been created in the
spherical LUVs as a result of peptide translocation across the
bilayer. For peptide SA-4 no such openings in the LUVs were
observed however surface distortion of liposome from the normal
rounded morphology could be visualized (Fig. 6).
Microscopic techniques such as SEM, TEM and AFM have been
used extensively for the elucidation of interaction of membrane active
peptides [43,44]. Based on different mode of cell perturbation
observed under electron microscope different modes of action has
been proposed for peptides with dissimilar structural preferences
[45].
SEM studies conducted with peptide SA-3 and SA-4 exhibited
different patterns of morphological effects caused by the peptides on
E. coli (Fig. 7). Within 30 min of incubation peptide SA-3 at 10×MIC
was able to perforate E. Coli cells whereas peptide SA-4 like many
other surface active peptides such as melittin caused surface swelling
and aggregation in E. coli cells [46]. The micrographs of peptide
treated E. coli cell makes it clear that the two peptides SA-3 and SA-4
act differently on model bacterial mimic membranes ( as evidenced
by dye leakage assay) as well as on intact E. coli ATCC 11775.
Further in confocal laser scanning microscopy at low concentra-
tion we observed translocation of peptide SA-3 across the membrane
in a non-membrane disruptive manner as has been observed for
peptides which operate by intracellular targeting such as buforins
[47]. However at the same concentration peptide SA-4 lysed E. coli
cells to death without entering into the cytoplasm as could be
visualized in differential contrast images (DIC) Fig. 8D. At a higher
concentration of 10 μg/ml internalization of FITC-tagged peptide SA-
3 lead to concomitant membrane damage. At the same concentration
peptide FITC-SA-4 also traversed the bacterial membrane, again
causing membrane rupture and formation of membrane debris
(Fig. 8). Similar to our results, in another study on interaction
between magainin 2 and CHO-K1 cells, cell translocation concomitant
with cell perturbation has been reported as the mode of action for the
peptide [48].
With ﬂow cytometric data (Fig. 9) we gained a quantitative picture
of concentration dependent internalization and membrane damage
potential of peptide SA-3 and SA-4 into the cytoplasm of E. coli ATCC
11775. In comparison to confocal data in our ﬂow cytometry data of
peptides with non-cell permeant dye PI a more pronounced
concentration dependent increase in ﬂuorescence was observed for
peptide SA-3, which can be ascribed to its better potency and rapid
bactericidal kinetics against E. coli.The PI uptake assay further potentiates the rapid membrane
translocation ability of peptide SA-3 which leads to formation of PI-
DNA complex quantitatively at higher concentration. However
peptide SA-4 was unable to cause signiﬁcant damages to bacterial
cell to reach intracellular DNA over the period of 15 min under the
experimental conditions.
The non-cell perturbing internalization tendency of peptide SA-3
prompted us to look for some intracellular targeting mode of action
for this peptide. With this aim we compared the relative afﬁnity of
peptides SA-3 and SA-4 to bind plasmid DNA (Fig. 10). In concordwith
our confocal microscopy data, in DNA binding assay for peptide SA-3
and SA-4 a preferential DNA binding afﬁnity of peptide SA-3 was
observed which was reﬂected as retardation in the movement of
plasmid DNA. Comparative binding assay revealed a higher afﬁnity of
peptide SA-3 for plasmid DNAwhich is suggestive of the probable role
of intracellular targeting as an alternative mode of bacterial killing
activity for the peptide. For indolicidin though complete retardation
was not observed at concentrations tested, a concentration dependent
retardation in movement of DNA was observed. The results suggest
better binding of DNAwith peptide SA-3 as compared to peptide SA-4
and indolicidin.
Current study on short, amphipathic template based CAMPs afford
us two lead peptides SA-3 and SA-4 with potent activity against
susceptible as well as multi-drug-resistant bacterial strains and
negligible hemolytic activity. Based on the results of all the
biophysical and microscopic data on peptide SA-3 and SA-4 we
propose intracellular targeting as primary mode of action for peptide
SA-3 whereas peptide SA-4 was more prone to membrane damage
mode of action. It has been well reported in the literature that Trp
content and position of Trp residue in a peptide can alter its mode of
interaction with the bacterial membrane [49]. On similar lines we
propose that presence of 3 Trp residues in the hydrophobic sector of
the amphipathic template of peptide SA-3 makes it more prone to
insert and translocation into the membrane of E. coli ATCC 11775 as
compared to peptide SA-4 which although has the same number of
hydrophobic residues but was lacking Trp residues at position 7 and
8 in the sequence. Membrane translocation and concentration
dependent membrane damage caused by these two peptides do not
however precludes them for other mechanism of action on different
bacterial cells however a distinction in the mode of cell permeation
against E. coli ATCC 11775 has been ascertained by the data presented
in the study. Further it would be interesting to study interactions of
the designed peptides with representative Gram-positive bacteria
such as S. aureus. In conclusion with different mode of cell
perturbation peptide SA-3 and SA-4 designed in the present study
can be further optimized for use in clinics.
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